BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 4130717)

  • 1. [Impaired immunologic reactivity as pacemaker for lymphoma development (author's transl)].
    Krüger G
    Verh Dtsch Ges Pathol; 1971; 55():200-4. PubMed ID: 4130717
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biology of the immunological tolerance (author's transl)].
    Katsura Y; Muramatsu S
    Tanpakushitsu Kakusan Koso; 1974 Sep; 19(10):939-48. PubMed ID: 4612621
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hormonal control of immune reactivity].
    Dimitrov V; Kosturkov G
    Vutr Boles; 1978; 17(4):8-15. PubMed ID: 358603
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunologic deficit in Hodgkin's disease. Clinical reflections and pathogenetic implications].
    Maggi E; Romagnani S; Ricci M
    Ann Ital Med Int; 1986 Mar; 1(1):54-65. PubMed ID: 3079355
    [No Abstract]   [Full Text] [Related]  

  • 5. [Suppressor activity in the immune system (author's transl)].
    Rivero SJ
    Rev Med Chil; 1979 Apr; 107(4):337-42. PubMed ID: 116338
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of immunosuppressive and cytostatic factors on immunological responses (experimental investigations in vivo and in vitro) (author's transl)].
    Duroś H; Kunicka A; Zagórska-Smogorzewska M
    Probl Med Wieku Rozwoj; 1975; 4():111-21. PubMed ID: 1167968
    [No Abstract]   [Full Text] [Related]  

  • 7. Intracamerally induced concomitant immunity: mice harboring progressively growing intraocular tumors are immune to spontaneous metastases and secondary tumor challenge.
    Niederkorn JY; Streilein JW
    J Immunol; 1983 Nov; 131(5):2587-94. PubMed ID: 6415174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunodeficiency and autoimmunity in aging.
    Makinodan T; Heidrick ML; Nordin AA
    Birth Defects Orig Artic Ser; 1975; 11(1):193-8. PubMed ID: 1170904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cell specific natural IgM autoantibodies: multifunctional regulators of the humoral immune response (a review).
    Uher F; Kiss K; Rácz J; Mihalik R; Puskás E; Alonso ME
    Acta Microbiol Immunol Hung; 1995; 42(1):3-17. PubMed ID: 7620810
    [No Abstract]   [Full Text] [Related]  

  • 10. [Disturbance of immune surveillance in tumor-bearing host (author's transl)].
    Haba S; Kitagawa M
    Tanpakushitsu Kakusan Koso; 1974 Sep; 19(10):930-8. PubMed ID: 4612620
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical significance of the transfer factor].
    Mutz I; Humphrey GB
    Wien Klin Wochenschr; 1973 May; 85(20):357-60. PubMed ID: 4574399
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunological aspects of lymphogranulomatosis].
    Blokhina NG; Agafonov VA; Bykovskaia SN; Naumova ER; Raushenbakh MO
    Ter Arkh; 1984; 56(10):125-30. PubMed ID: 6098042
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cellular mechanisms in induction of antibody response (author's transl)].
    Saito K
    Tanpakushitsu Kakusan Koso; 1974 Sep; 19(10):916-29. PubMed ID: 4140548
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunity and hypersensitivity in Hodgkin's lymphoma].
    Leoni P; Marchegiani G; Montillo M; Centurioni R; Montroni M; Danieli G
    Minerva Med; 1982 May; 73(20):1361-9. PubMed ID: 6210855
    [No Abstract]   [Full Text] [Related]  

  • 15. [Basic neuro-immunological concepts].
    Meyer-Rienecker HJ
    Psychiatr Neurol Med Psychol (Leipz); 1972 Nov; 24(11):625-39. PubMed ID: 4585365
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanisms of tumor-induced immunological deficiencies and their possible significance in relation to the use of immunopotentiators in tumor-bearing hosts.
    Kerbel RS
    Biomedicine; 1974 Jul; 21(7):253-61. PubMed ID: 4547979
    [No Abstract]   [Full Text] [Related]  

  • 17. Analysis of immunological reactivity in skin-allograft tolerating rats.
    Chutná J; Hasek M; Viklický J; Bubeník J
    Folia Biol (Praha); 1973; 19(4):252-60. PubMed ID: 4584721
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cancer and immunity].
    Nagel GA; Geiger C
    Schweiz Med Wochenschr; 1971 Nov; 101(45):1605-20. PubMed ID: 4947152
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
    Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
    Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Autoimmunity and autoaggression].
    von Baehr R; Schwenke H
    Z Gesamte Inn Med; 1974 Apr; 29(8):316-22. PubMed ID: 4605520
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.